When you are prescribed lithium, the conversation about side effects almost always turns to your kidneys. For decades, the National Institute of Mental Health has recognized lithium as a mainstay of treatment for bipolar disorder, particularly because of its unmatched ability to reduce the risk of suicide. But the fear of long-term lithium kidney damage leads many patients to refuse it entirely, and leads some providers to underprescribe what could be a life-saving medication.
The reality of how lithium affects renal function is nuanced. It is absolutely true that lithium is processed almost entirely by the kidneys, and long-term use can cause structural changes over a period of decades. However, the narrative that lithium inevitably destroys your kidneys is simply not supported by modern clinical data. When dosed precisely and monitored consistently by a specialist who understands the condition, the risk of severe kidney disease is remarkably low.
If you have been avoiding or questioning your treatment because of these concerns, a consult with a bipolar specialist is a low-commitment way to see what different care could look like and get an honest assessment of your medication options.
At a Glance
- Lithium can cause nephrogenic diabetes insipidus (NDI) in up to 40% of patients on long-term treatment.
- A major meta-analysis found a 25.5% overall prevalence of impaired kidney function in long-term lithium users.
- Recent cohort data shows a 1.35 adjusted hazard ratio for stage 3 chronic kidney disease, but no increased risk for end-stage kidney disease.
- American Psychiatric Association guidelines recommend checking kidney function every 2-3 months during the first 6 months of treatment.
How Lithium Affects the Kidneys
To understand the relationship between lithium kidney function and bipolar disorder, it helps to look at exactly how the body processes the medication. Unlike many psychiatric drugs that are metabolized by the liver, lithium is a salt that is filtered almost entirely by your renal system. As your kidneys filter your blood, they reabsorb lithium along with sodium and water, passing it through the delicate tubular structures that concentrate your urine.
The structural changes caused by lithium happen slowly, typically over a decade or more of continuous use. It begins with microscopic scarring in the renal tubules, a condition known clinically as tubulointerstitial nephropathy. Over time, this scarring can mildly reduce your glomerular filtration rate (eGFR), which is the standard measure of how efficiently your kidneys are filtering waste from your bloodstream. A declining eGFR is the primary marker of lithium nephropathy.
It is important to understand that a mild drop in eGFR does not mean your kidneys are actively failing. Kidney function naturally declines as we age, and lithium accelerates this process slightly in some individuals. The clinical goal of your care team is not to prevent any physiological change whatsoever, but to manage the medication dosage and monitor the blood levels so that the decline never reaches a dangerous, irreversible threshold. This is why regular monitoring is non-negotiable for anyone taking the medication long-term.
The Dangers of Dehydration
While the long-term scarring happens slowly, there is a more immediate risk that patients must manage daily. Because your kidneys process lithium alongside sodium, any state of dehydration causes your kidneys to aggressively hold onto both. If you become severely dehydrated from illness, excessive sweating, or not drinking enough water, your kidneys will reabsorb lithium at a much higher rate.
This rapid reabsorption spikes your lithium blood levels and can lead to acute lithium toxicity. Toxicity itself causes sudden, acute stress on the renal system, which can accelerate long-term damage. The simplest, most effective way to protect your kidney function while on lithium is to maintain consistent, adequate hydration every single day, without exception.
Nephrogenic Diabetes Insipidus Explained
The most common and immediate way that lithium for bipolar disorder impacts your kidneys is by interfering with their ability to concentrate urine. Over years of treatment, the constant presence of lithium in the renal tubules can block the kidneys’ ability to respond to antidiuretic hormone (ADH). ADH is the signal that tells your kidneys to hold onto water rather than excreting it.
When lithium blocks this vital signal, your kidneys excrete large volumes of dilute urine, a condition known as nephrogenic diabetes insipidus (NDI). This is why extreme thirst and frequent urination are such ubiquitous side effects of the medication. Lithium can cause nephrogenic diabetes insipidus in up to 40% of patients on long-term treatment, making it one of the most widespread renal complications of the treatment.
While frequent urination is primarily a quality-of-life nuisance, it carries a very real clinical risk. If you have NDI, you are losing fluid at a much faster rate than normal. If you cannot drink enough water to keep up with this accelerated fluid loss, you will become dehydrated rapidly, which loops back into the risk of lithium toxicity. If you notice a sudden, dramatic increase in your thirst and urination, bringing this to your provider’s attention allows them to check and adjust your lithium blood levels if necessary.
Key Takeaway: Extreme thirst and frequent urination are signs that lithium is blocking your kidneys’ ability to concentrate urine, a condition that requires you to be hyper-vigilant about daily hydration.
What the Research Shows About Chronic Kidney Disease
The intense fear surrounding lithium and total kidney failure often stems from older data, collected during an era when target lithium blood levels were kept much higher than they are in modern clinical practice. Today’s research paints a clearer, far less catastrophic picture of the actual risks involved with long-term lithium therapy.
A comprehensive meta-analysis published in the journal Bipolar Disorders examined data from over 25,000 patients and found an overall prevalence of 25.5% for impaired kidney function among those on long-term lithium. When compared to patients taking other medications for their mood disorder, the odds ratio of impaired kidney function in 14,187 lithium-treated patients was 2.09. This confirms beyond a doubt that lithium does indeed increase the risk of developing chronic kidney disease (CKD) compared to the general population.
However, the severity of that disease matters immensely when making clinical decisions. A recent population-based cohort study analyzing thousands of patients found that lithium users had a 1.35 adjusted hazard ratio for stage 3 chronic kidney disease compared to those on other mood stabilizers. Crucially, the exact same study found no between-group difference in the risk of end-stage kidney disease. The research explicitly noted that mean lithium serum levels greater than 0.5865 mEq/L represented thresholds associated with stage 3 chronic kidney disease.
In other words, while lithium increases the chance of developing mild to moderate (Stage 3) kidney impairment, it does not significantly increase the risk of total kidney failure requiring dialysis. Stage 3 CKD sounds terrifying, but it is often entirely asymptomatic and highly manageable. For a patient with severe bipolar disorder, maintaining profound mood stability on lithium with Stage 3 CKD is almost always a vastly better clinical outcome than experiencing recurrent, life-threatening mood episodes on a less effective, kidney-sparing medication.
The Required Monitoring Schedule for Lithium
Because lithium affects renal function predictably and slowly, severe kidney damage is highly preventable with simple, routine blood work. Safe lithium treatment requires a structured monitoring plan in place. The primary markers your provider will track are serum creatinine (a waste product your kidneys filter) and your eGFR, alongside the actual concentration of lithium in your blood.
According to American Psychiatric Association guidelines, kidney function should be assessed every 2-3 months during the first 6 months of treatment. Once your blood levels and kidney function are proven to be stable, this testing can safely be spaced out to every 6 to 12 months. Your provider will also monitor your thyroid function, as lithium frequently causes hypothyroidism, which requires its own management.
What to Avoid Between Blood Tests
While your provider monitors your lab results, you can protect your kidneys through your daily choices. Beyond hydration, being vigilant about other medications that interact with lithium or stress the kidneys matters significantly. Non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, naproxen, or high-dose aspirin reduce blood flow to the kidneys. This reduction in blood flow can cause your lithium levels to spike dangerously high within days.
Blood pressure medications, particularly ACE inhibitors and diuretics, also drastically alter how your kidneys process lithium and require close coordination with your prescribing clinician. If you are ever prescribed a new medication for a physical health condition, informing your bipolar specialist allows them to adjust your lithium dose or monitoring schedule accordingly.
Balancing the Risk: Kidney Decline vs. Bipolar Relapse
When a patient on long-term lithium begins to show a decline in their eGFR on routine lab work, the immediate reaction from both the patient and sometimes the provider is a desire to stop the medication immediately. It is true that stopping lithium slowed down mean eGFR decline in clinical studies, preserving the remaining kidney function.
However, stopping lithium abruptly—or even tapering it slowly over several weeks—carries a profound and often immediate risk of psychiatric relapse. As the National Institute of Mental Health notes, mood stabilizers such as lithium or valproate can help prevent mood episodes. Bipolar disorder has one of the highest mortality rates of any psychiatric illness, primarily due to suicide and the cardiovascular complications associated with severe manic and depressive episodes. As many as 15 percent of those affected die by suicide, a risk that lithium uniquely and powerfully mitigates.
The clinical decision to stop lithium must meticulously weigh the certainty of psychiatric risk against the probability of renal progression. A landmark decision analysis concluded that stopping lithium would only be an option if the likelihood of progression to end-stage renal disease exceeded 41.3%, or if alternative medications perfectly prevented relapse. Because alternative medications like anticonvulsants rarely offer the exact same prophylactic benefit, specialists often choose to continue lithium even in the presence of mild CKD, opting instead to lower the dose to the absolute minimum effective level and increase the frequency of lab monitoring.
Key Takeaway: Discontinuing lithium due to mild kidney changes often carries a higher risk of fatal psychiatric relapse than the risk of progressing to severe kidney disease.
How Precision Medicine Protects Your Kidneys
The historical approach to lithium dosing was rigid and aggressive: aim for a blood level of 0.8 to 1.0 mEq/L for everyone, regardless of their individual biology or where they were in their illness course — a threshold range associated with higher risk of Stage 3 CKD in long-term users. We now know that keeping lithium levels higher than absolutely necessary is the primary driver of kidney impairment. Precision medicine fundamentally changes this paradigm.
A bipolar-specialized clinician will actively seek the lowest effective dose for your specific neurobiology. For many patients in the maintenance phase of bipolar relapse prevention, a blood level closer to 0.6 mEq/L — below the 0.5865 mEq/L threshold associated with CKD3+ — provides excellent mood stability while dramatically reducing the toxic burden on the renal system over the decades.
Furthermore, precision care means evaluating the entire metabolic and physical picture. If you are taking other medications that stress the kidneys, or if you have early-stage hypertension or diabetes, a specialist will address those compounding factors comprehensively rather than simply blaming the lithium. This integrated, individualized approach allows many patients to safely remain on their most effective mood stabilizer for the rest of their lives without ever progressing to severe renal failure.
If you’re tired of piecing together your own care plan and want a team that handles monitoring proactively, explore how Sway Health coordinates these labs as part of your ongoing care plan.
Frequently Asked Questions
Can lithium-induced kidney damage be reversed?
Early functional changes, such as the increased urination associated with nephrogenic diabetes insipidus, often improve significantly if the dose is lowered or the medication is stopped. However, the structural scarring that causes a drop in your eGFR is generally permanent, though research shows that stopping lithium slowed down mean eGFR decline. A bipolar-specialized clinician can help determine if a careful dose adjustment is a safer intervention than stopping the medication entirely.
How long does it take for lithium to affect the kidneys?
While increased thirst and urination can begin within weeks or months of starting treatment, actual chronic kidney disease typically takes over a decade of continuous, long-term use to develop, with significant impairment most common after sustained exposure. Regular lab monitoring catches these slow functional changes years before they become clinically dangerous.
What are the first signs of kidney problems from lithium?
The most common early physical sign is polyuria, which means producing large volumes of dilute urine, accompanied by relentless, excessive thirst. However, a drop in your eGFR (the primary marker for chronic kidney disease) has absolutely no physical symptoms in its early to moderate stages, which is exactly why routine blood tests are mandatory and cannot be skipped.
Conclusion: Making an Informed Decision
The relationship between lithium and your kidneys requires clinical respect, but it does not require fear. While long-term use definitively increases the risk of developing mild to moderate chronic kidney disease, the actual risk of total kidney failure is exceptionally low when the medication is dosed precisely and monitored regularly by a specialist. The profound protective benefits of lithium—preventing devastating manic and depressive episodes and drastically reducing the risk of suicide—often far outweigh the renal risks for the vast majority of patients.
If you want a conversation with a bipolar-specialized clinician about your medication options, monitoring plan, or the trade-offs of long-term lithium treatment, Sway Health coordinates exactly these decisions as part of integrated bipolar care — not as a separate consult, but as part of your ongoing care relationship.
